NP90323(a) Botulinum Toxin Type A Medicines (Botox®)

Award

Buyers

Value

£8,051,564

Suppliers

Classifications

  • Pharmaceutical products

Tags

  • award
  • contract

Published

1 year ago

Description

Supply of Botulinum Toxin Type A Medicines(Botox®) to NHS Scotland:
NP90323(a): Botulinum Toxin Type A Injection 50-unit vial/ Botulinum Toxin Type A Injection 100-unit vial/ Botulinum Toxin Type A Injection 200-unit vial (Botox®)

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download

  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

Open

Supply of Ready to Administer Products

The East Midlands Pharmacy Collaborative (EMPC) as the Contracting Authority wishes to establish a multi-provider Framework Agreement for the Supply of Ready to Administer Products as defined in the specification. The contract will commence on 1st July 2025 until 30th June 2027. The contract shall run for a period of 24 months with an option to extend for a further 24 months Additional information: To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: [email protected]

East Midlands Pharmacy Collaborative

East Midlands Pharmacy Collaborative

Published 3 days ago
Open

Ready to Administer Products

The East Midlands Pharmacy Collaborative (EMPC) as the Contracting Authority wishes to establish a multi-provider Framework Agreement for the Supply of Ready to Administer Products on behalf of its member Trusts.

University Hospitals of Derby and Burton NHS Foundation Trust

University Hospitals of Derby and Burton NHS Foundation Trust

Published 3 days ago
Open

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1st May 2024

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 01 May 2025 Offer reference number: CM/PHR/22/5683 CM/PHR/22/5683/00 - NHS Framework Agreement for Branded Medicines - Proprietary Category Tender: Period of Framework Agreement: 01 May 2025 to 30 April 2029 Additional information: To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: [email protected]

NHS England

NHS England

Published 3 days ago

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Organisation

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Body governed by public law

Michelle Semple

[email protected]

Timeline complete

Publish
Bid
Evaluate
Award
Complete